drugset / Trial / NCT00552032
Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether 8 weeks treatment with mometasone furoate nasal spray (MFNS), twice daily, is safe and effective in treating adenoid hypertrophy in children.
Timeline
- Start
- 2007-08-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 50 ug | Intranasal |